Drug company experts advised staff to withhold data about SSRI use in children

Wayne Kondro

Canadian Medical Association Journal · 2004 · 80 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

An internal document advised staff at the international drug giant GlaxoSmithKline (GSK) to withhold clinical trial findings in 1998 that indicated the antidepressant paroxetine (Paxil in North America and Seroxat in the UK) had no beneficial effect in treating adolescents. ![Figure][1]</img>